 | Up a level |
Journal Article
Camidge, Ross, Cappuzzo, Federico, Go, Jowell, Isaacson, Jeffrey, Litten, Jason, Park, Keunchil, Spigel, David R., Spira, Alexander, Vergnenegre, Alain, Wolf, Juergen, Yang, James Chih-Hsin and Mok, Tony (2015). TIGER-1: A Phase 2/3 Study of First Line Rociletinib or Erlotinib in EGFR-Mutant NSCLC. J. Thorac. Oncol., 10 (9). S. S427 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380
Skoulidis, Ferdinandos, Li, Bob T., Dy, Grace K., Price, Timothy J., Falchook, Gerald S., Wolf, Jurgen, Italiano, Antoine, Schuler, Martin, Borghaei, Hossein, Barlesi, Fabrice, Kato, Terufumi, Curioni-Fontecedro, Alessandra 
ORCID: 0000-0002-5778-5270, Sacher, Adrian ORCID: 0000-0001-7865-2701, Spira, Alexander, Ramalingam, Suresh S., Takahashi, Toshiaki, Besse, Benjamin, Anderson, Abraham, Ang, Agnes, Tran, Qui ORCID: 0000-0002-0760-964X, Mather, Omar, Henary, Haby, Ngarmchamnanrith, Gataree, Friberg, Gregory, Velcheti, Vamsidhar and Govindan, Ramaswamy
(2021).
Sotorasib for Lung Cancers with KRAS p.G12C Mutation.
N. Engl. J. Med., 384 (25).
S. 2371 - 2382.
WALTHAM:
MASSACHUSETTS MEDICAL SOC.
ISSN 1533-4406
Subbiah, Vivek, Wolf, Jurgen, Konda, Bhavana, Kang, Hyunseok, Spira, Alexander, Weiss, Jared, Takeda, Masayuki, Ohe, Yuichiro, Khan, Saad, Ohashi, Kadoaki, Soldatenkova, Victoria, Szymczak, Sylwia, Sullivan, Loretta, Wright, Jennifer and Drilon, Alexander (2022). Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial. Lancet Oncol., 23 (10). S. 1261 - 1274. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488